PTC Therapeutics (PTCT)
(Delayed Data from NSDQ)
$31.73 USD
+0.80 (2.59%)
Updated Jul 8, 2024 04:00 PM ET
After-Market: $31.74 +0.01 (0.03%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth F Momentum C VGM
Industry / Sector Report
Industry : Medical - Drugs
Zacks Industry Rank
Top 39% (98 out of 249)Zacks Sector Rank
Top 31% (5 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 2.62 | 1.52 | 9.99 |
Current Quarter Estimate | -1.01 | -2.04 | 61.00 |
Year Ago Quarter Estimate | -2.66 | -0.59 | 54.84 |
Next Quarter Estimate | -1.38 | -2.00 | 63.00 |
Next Year Estimate | -3.35 | 6.92 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -35.36 | 14.00 | 15.67 |
Next Year | 31.63 | 15.00 | 9.31 |
Last 5 Years | -289.40 | 7.00 | 8.10 |
Next 5 Years | 39.90 | 25.10 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -5.88 |
Price/Book (MRQ) | NA | 1.74 |
Price/Cash Flow (MRFY) | 12.77 | 7.93 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -62.45% | -2,822.50% |
Return on Equity (TTM) | NA | -71.77% |
Debt to Equity (MRQ) | NA | 0.08 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.